Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2

Author(s):  Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy

Issue:  Sep/Oct 2021 - Volume 25, Number 5
View All Articles in Issue

Abstract:  Container-closure integrity provides assurance that compounded sterile preparation quality attributes are met throughout its shelf life. Since compounded sterile preparations lacking container-closure integrity are considered adulterated as per the Federal Food, Drug and Cosmetic Act and are therefore unsafe for patient use, compounders must be able to produce a well closed sealed vial. Furthermore, 503B outsourcing facilities must qualify the capping process as described by the proposed “Current Good Manufacturing Practice – Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug and Cosmetic Act Guidance for Industry.” This article is the second in a series describing vial crimping and capping equipment selection and the qualification necessary to create a well-closed sealed vial in a Current Good Manufacturing Practice environment to ensure patient safety and maintain compliance.

Related Keywords: Doral (Neal) O. Higgins, Melanie J. Prudom, MBA, Amy Summers, PharmD, BCSCP, container-closure integrity, container-closure system, U.S. Food, Drug and Cosmetic Act, vial sealing, compounded sterile preparations, capper devices, crimper devices, vial-capping qualification process, installation qualification, operational qualification, performance qualification, drug safety

Related Categories: LEGAL, PACKAGING, STERILE PREPARATIONS, QUALITY CONTROL

Printer-Friendly Version




Download in electronic PDF format for $45

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2 Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy Sep/Oct 2021 389-395 Buy
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1 Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy Jul/Aug 2021 298-302 Buy
How to Qualify Container Closure Systems for Intended Use, Part 1 Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page Nov/Dec 2019 454-461 Buy
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Allen Loyd V Jr Jul/Aug 2021 311-317 Buy
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems Vaughn Stacey R, Radwick Allison Jan/Feb 2020 14-19 Buy
Choosing a Vial Processing Line for Aseptic Compounding: Part 1 Noorian Shaun, Vahedi Navid Jul/Aug 2016 283-292 Buy
Evaluation of the Efficacy and Superiority of Different Vial Rubber Closure Disinfection Techniques Bjornstad Matthew, Kosinski Tracy, Burlage Robert Sep/Oct 2020 434-438 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
Accuracy Considerations in Sterile Compounding Akers Michael J Mar/Apr 2017 133-142 Buy
Child-safety Containers/Devices and Compounding Allen Loyd V Jr Sep/Oct 2017 364-370 Buy